Grants and Contributions:
Title:
802368
Agreement Number:
802368
Agreement Value:
$950,000.00
Agreement Date:
Apr 1, 2012 - Mar 31, 2014
Description:
Further development and testing of a platform that uses a human protein combined with cancer drugs to target cancer cells while bypassing healthy cells.
Organization:
Innovation, Science and Economic Development Canada
Location:
Toronto, Ontario, CA M5G1L7
Reference Number:
033-2012-2013-Q2-802368
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
838331098
Recipient Type:
For-profit organization
Recipient's Operating Name:
Alpha Cancer Technologies Inc.
Recipient's Legal Name:
Alpha Cancer Technologies Inc.
Federal Riding Name:
University--Rosedale
Federal Riding Number:
35110
Program:
Federal Economic Development Department for Ontario
NAICS Code:
541710